WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone, in a case that could have far-reaching implications for millions of American women and for scores of drugs regulated by the Food and Drug Administration.
It’s the first abortion-related case the court has taken since a majority of the current justices struck down the constitutional right to abortion in 2022.
A group of anti-abortion doctors had asked the court to restrict access to mifepristone and to limit when in a pregnancy it could be used.
Key moments from the arguments:
Related articles:
Related suggestion:
How Kim Kardashian's breathtaking silver corset proves the dangerous centuriesAirbnb shares slide on lower revenue forecast despite a doubling of net income64 people charged in sexual abuse investigations in Canada, Ontario police sayAlgeria's leader demands justice over French colonialSteward Health Care says it is selling the 30+ hospitals it operates nationwideBiden says US won't supply weapons for Israel to attack RafahBrayan Rocchio's RBI hit in the 10th gives the Guardians a 5Jean Smart reveals Harry Styles' cheeky 'hack' for checking into hotels undercoverCalifornia girl, 14, is charged with the murder of human trafficking nonSteward Health Care says it is selling the 30+ hospitals it operates nationwide
3.305s , 6496.828125 kb
Copyright © 2024 Powered by 5 takeaways from the abortion pill case before the U.S. Supreme Court ,Global Gazette news portal